安利股份涨2.06%,成交额2757.76万元,主力资金净流出144.78万元

Core Viewpoint - Amway Co., Ltd. has experienced fluctuations in stock price and financial performance, with a notable decrease in revenue and net profit year-on-year, indicating potential challenges ahead for the company [1][2]. Financial Performance - As of November 20, 2025, Amway reported a revenue of 1.679 billion yuan, a year-on-year decrease of 6.84% [2]. - The net profit attributable to shareholders was 121 million yuan, reflecting a year-on-year decline of 19.22% [2]. - The company's stock price has increased by 11.39% year-to-date but has seen a decline of 0.59% over the last five trading days and a significant drop of 34.17% over the past 60 days [1]. Shareholder Information - The number of shareholders as of November 20, 2025, was 18,000, a decrease of 2.28% from the previous period [2]. - The average number of circulating shares per shareholder increased by 2.34% to 12,003 shares [2]. Dividend Distribution - Amway has distributed a total of 341 million yuan in dividends since its A-share listing, with 131 million yuan distributed over the past three years [3]. Institutional Holdings - As of September 30, 2025, new institutional shareholders include Yongying Advanced Manufacturing Mixed Fund and China Europe Enjoy Life Mixed Fund, among others [3]. - Notably, Guotai Junan's value advantage flexible allocation mixed fund reduced its holdings by 5.05 million shares [3].